Skip to main content
Back
Watch Compare

Longevity Health Holdings, Inc.

Data quality: 100%
Also listed as XAGEW OTC
XAGE
OTC Manufacturing Chemicals
$0.35
▲ $0.03 (10.76%)
Mkt Cap: 663,386.0
Price
$0.27
Mkt Cap
663,386.0
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -3.34 M
Capital efficient — spends only 0.74% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)3701.44%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-361.00%
Op. Margin-371.58%

Safety

Debt / Equity
N/A
Current Ratio0.42
Interest Coverage-390.23

Valuation

PE (TTM)
-0.10
Above sector avg (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -0.1 -1.5
P/B — 1.6
ROE % — -54.4
Net Margin % -361.0 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2026 — 72.71 M —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 3701.44% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.91 M Net Income (TTM) -6.91 M
ROE N/A ROA -196.78%
Gross Margin 57.23% Operating Margin -371.58%
Net Margin -361.00% Free Cash Flow (TTM) -3.34 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.42
Interest Coverage -390.23 Asset Turnover 0.55
Working Capital -4.00 M Tangible Book Value -3.99 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.10 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -504.00%
Market Cap 663,386.0 Enterprise Value 663,386.0
Per Share
EPS (Diluted TTM) -4.83 Revenue / Share 0.77
FCF / Share -1.35 OCF / Share -1.35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.74% FCF Conversion 48.42%
SBC-Adj. FCF -4.03 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue 1.91 M 50,318.0 — — —
Net Income -6.91 M -10.37 M -15.45 M -329,382.0 204,997.0
EPS (Diluted) -4.83 -0.49 -1.46 — —
Gross Profit 1.09 M 43,961.0 — — —
Operating Income -7.11 M -5.00 M -5.94 M -467,431.0 -1.65 M
EBITDA — — — — —
R&D Expenses 788,888.0 1.05 M 2.50 M — —
SG&A Expenses — — — — —
D&A 78,675.0 83,486.0 97,113.0 — —
Interest Expense 18,214.0 29,446.0 — — —
Income Tax 36,262.0 -97,279.0 0.0 0.0 391,198.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 2.37 M 1.47 M 63.95 M 155.42 M 156.98 M
Total Liabilities 8.23 M 6.19 M 39.20 M 5.74 M 7.09 M
Shareholders' Equity -5.87 M -4.71 M 24.75 M -4.76 M -6.02 M
Total Debt — — — — —
Cash & Equivalents 706,740.0 — 2.91 M 774,192.0 —
Current Assets 1.95 M 955,554.0 62.90 M 973,175.0 285,202.0
Current Liabilities 7.92 M 5.88 M 38.50 M 330,007.0 1.68 M